In a report released yesterday, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Pfizer (PFE – Research Report), with a ...

Whatever the case, the fundamentals of a politically supportive backdrop for Novavax’s traditional approach to vaccines could easily boost NVAX stock under Trump’s second administration. With that in ...

Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks.

A post-marketing review by the FDA detected an increased risk of the autoimmune condition in patients inoculated with GSK’s ...

SEC Filings provided by EDGAR Online, Inc.